
GC18602
p38 MAPK Inhibitor IV
Also known as 3,4,6-trichloro-2-(2,3,5-trichloro-6-hydroxyphenyl)sulfonylphenol
p38 MAPK Inhibitor IV is a highly specific ATP-competitive p38α MAPK inhibitor with IC50s of 0·13 and 0·55 μM for p38α and p38β MAPK, respectively
ChemicalCAS1638-41-1MW456.9FormulaC12H4Cl6O4S
- CAS number
- 1638-41-1
- Molecular weight
- 456.9
- Formula
- C12H4Cl6O4S
- Solubility
- 2·5 mg/ml in DMSO, 2 mg/mL in DMF
- InChIKey
- AKUKHICVNCCQHN-UHFFFAOYSA-N
- Catalogue number
- GC18602
- Brand
- GLPBIO
Computed properties PubChem CID 3816490 · XLogP 6.9 · TPSA 83 Ų · H-bond donors 2
- XLogP
- 6.9
- TPSA
- 83 Ų
- H-bond donors
- 2
- H-bond acceptors
- 4
- Rotatable bonds
- 2
- Heavy atoms
- 23
SMILES C1=C(C(=C(C(=C1Cl)Cl)S(=O)(=O)C2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl
Computed descriptors from PubChem (CID 3816490), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il